Company Events

——China’s Dexamethasone sodium phosphate API gains CEP certification, confirming quality excellence and boosting the global presence of Chinese API manufacturers and pharmaceutical raw material suppliers.

——Telmisartan Process II API gains CEP certification, enhancing purity, sustainability, and global market access for leading API manufacturers and suppliers.

——Dual-Enzyme Process Redefines Sustainable Pharmaceutical Manufacturing A leading biotechnology enterprise in Northwest China has commenced commercial production of Ursodeoxycholic Acid (UDCA) active pharmaceutical ingredient (API), marking the region's inaugural transition from bulk intermediates